PATENT CLAIM ANALYSIS

Application Number: 15745066
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "057000"]

Abstract:
The present disclosure provides formulations for pharmacologically active reagents, including formulations based on particulates formed from a biodegradable polymer (e.g., a polysaccharide such as dextran) linked to a vitamin or related agent (e.g., folic acid). Hydrophobic pharmaceutically active agents (such as anti-cancer drugs, e.g., paclitaxel) are encapsulated into the polysaccharide-vitamin conjugate for the administration of paclitaxel. The active agent is in a core portion of the particulate, instead of on the surface of the particulate. Processes for making and using the particulates and compositions comprising the same are also disclosed. In particular, methods of cancer diagnosis and treatment are provided.

Claim (Index 10):
The particulate of  claim 1 , wherein the one or more molecules of vitamin or analogue or derivative are hydrophobic.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.63889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14428210', '10659501', '14671790', '14216127', '12296428']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.706558746791168
- 35 USC 102 Novelty (BERT): 0.5013501054248349
- Combined Prediction Score: 0.6860378826545347
- Mean Citation Score: 181.04732
- Max Citation Score: 193.8111
- Similarity Product: 122.93211527295117

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test